CK Life Sciences International Overview

  • Founded
  • 2000

Founded
  • Status
  • Public

  • Employees
  • 1,855

Employees
  • Stock Symbol
  • 00775

Stock Symbol
  • Investments
  • 13

  • Share Price
  • $0.11

  • (As of Wednesday Closing)

CK Life Sciences International General Information

Description

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a global presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
HKG
Primary Office
  • 2 Dai Fu Street
  • Tai Po Industrial Estate
  • Hong Kong
  • Hong Kong
+852 2126 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CK Life Sciences International Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.07 - $0.16 $1.02B 9.6B 32.4M

CK Life Sciences International Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,618,484 1,618,484 1,778,371 1,661,962
Revenue 695,018 695,018 637,174 633,900
EBITDA 74,814 74,814 60,055 72,996
Net Income 20,945 20,945 16,145 23,193
Total Assets 1,504,351 1,504,351 1,545,037 1,375,676
Total Debt 796,737 796,737 798,532 722,932
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CK Life Sciences International Executive Team (3)

Name Title Board Seat Contact Info
Kam Lam Chief Executive Officer, President, Executive Director & Member of Nomination Committee
Ying Choi Yu Vice President, Chief Executive Officer, Executive Director and Compliance Officer
You’re viewing 2 of 3 executive team members. Get the full list »

CK Life Sciences International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CK Life Sciences International Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 01-Dec-2018 000000000 Buildings and Property
00000000 16-Nov-2017 0000000000 Drug Delivery
0000000 00000 01-Jan-2014 0000000000 Distributors/Wholesale
00000000 0000 29-Nov-2012 0000000000 00000 Food Products 000 000
Peaty Trading Group 04-Jan-2012 Merger/Acquisition 000.00 Agricultural Chemicals
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

CK Life Sciences International Subsidiaries (5)

Company Name Industry Location Founded
Polynoma Drug Delivery San Diego, CA 2007
0000 0000000000000 Pharmaceuticals Minto, Australia 0000
0000000 0000000000 Distributors/Wholesale Adelaide, Australia 0000
000 00000000000000 Drug Delivery Vancouver, Canada 0000
00000000 0000 Food Products Melbourne, Australia 0000
To view CK Life Sciences International’s complete subsidiaries history, request access »